EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Engaging community oncology stakeholders to plan multisite cancer caregiving research (CONNECT WF-2300CD)

Sarah S Asad iD, Beverly J Levine, Anna C Snavely iD, Kathryn E Weaver iD, Michael K Farris iD, Sarah N Price iD, Melyssa Foust iD, Kristi D Graves iD, Chad Dingman, Martha S Tingen iD, Jenni Danai, Jessica Sheedy und 2 weitere

JNCI Cancer Spectrum · 07.07.2026 · 10 (4)

DOI: 10.1093/jncics/pkag065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 22.06.2026. Verfasst von Sarah S Asad und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States. Hauptthemen laut MEDLINE: Caregivers, Neoplasms, Clinical Trials as Topic, Multicenter Studies as Topic. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute at the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Engaging community stakeholders in clinical trials planning identifies participation barriers and facilitators to support future trial success. We assessed interest and perceived capacity of the National Cancer Institute Community Oncology Research Program (NCORP) practices and engaged stakeholders to inform a future multisite clinical trial involving caregivers.

Methods

A cross-sectional survey of NCORP practices (WF-2300CD) assessed interest (somewhat or very likely to participate) and capacity (ie, criteria: ≥5 eligible dyad accruals per quarter, identification of necessary study implementers) and barriers and facilitators to participating in a future cancer caregiver–focused trial. Interest and capacity were estimated with 95% confidence intervals (CIs), and logistic regression was used to identify statistically significant predictors. Free-text responses were analyzed using content analysis.

Results

Among 136 initial responding practices, 126 (92%) completed the survey (November 2023–April 2024), 56% saw at least 1000 new patient cases annually, 13.5% served at least 30% racial and ethnic minority patients, and 13.5% were designated critical access hospitals. Overall, 84.9% (95% CI = 77.5% to 90.1%) expressed interest in a caregiver-focused trial, but only 37.3% (95% CI = 28.9% to 46.4%) met all capacity criteria; capacity was the sole predictor of interest (adjusted odds ratio [OR] = 5.79, 95% CI = 1.23 to 27.13). Most (88.9%) practices estimated 5 or more eligible caregiver–patient dyads per quarter, but only 44.4% believed they could accrue that amount. Key participation barriers included staffing limitations and challenges related to eligibility and recruitment. Practices emphasized clear guidance on dyad eligibility, recruitment materials, workflow training, and resource considerations to improve trial participation.

Conclusion

Early stakeholder engagement identified actionable barriers and produced practice-aligned strategies to enhance caregiver trial participation in community oncology settings. Targeted capacity building may improve participation for future caregiver-focused trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaregiversNeoplasmsClinical Trials as TopicMulticenter Studies as TopicStakeholder ParticipationMedical OncologyHumansCross-Sectional StudiesUnited StatesNational Cancer Institute (U.S.)Logistic ModelsSurveys and QuestionnairesPatient SelectionFemale

Autor:innen und Institutionen

  • Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
  • Section on Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
  • Upstate Carolina National Cancer Institute Community Oncology Research Program, Greer, SC, United States.
  • Georgetown University Medical Center, Washington, DC, United States.

ORCID-Profile: Sarah S Asad, Anna C Snavely, Kathryn E Weaver, Michael K Farris, Sarah N Price, Melyssa Foust, Kristi D Graves, Martha S Tingen, Bonny Morris, Chandylen Nightingale

Förderung

  • NCI NIH HHS
  • National Cancer Institute at the National Institutes of Health

Zitieren

APA

Asad, S. S., Levine, B. J., Snavely, A. C., Weaver, K. E., Farris, M. K., Price, S. N., Foust, M., Graves, K. D., Dingman, C., Tingen, M. S., Danai, J., Sheedy, J., Morris, B., & Nightingale, C. (2026). Engaging community oncology stakeholders to plan multisite cancer caregiving research (CONNECT WF-2300CD). JNCI Cancer Spectrum, 10(4). https://doi.org/10.1093/jncics/pkag065

Vancouver

Asad SS, Levine BJ, Snavely AC, Weaver KE, Farris MK, Price SN, et al. Engaging community oncology stakeholders to plan multisite cancer caregiving research (CONNECT WF-2300CD). JNCI Cancer Spectrum. 2026;10(4). doi:10.1093/jncics/pkag065

BibTeX
@article{Asad2026,
  author = {Asad, Sarah S and Levine, Beverly J and Snavely, Anna C and Weaver, Kathryn E and Farris, Michael K and Price, Sarah N and Foust, Melyssa and Graves, Kristi D and Dingman, Chad and Tingen, Martha S and Danai, Jenni and Sheedy, Jessica and Morris, Bonny and Nightingale, Chandylen},
  title = {Engaging community oncology stakeholders to plan multisite cancer caregiving research (CONNECT WF-2300CD)},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1093/jncics/pkag065}
}
Kostenlos starten →